Tissue Regenix Group (LSE:TRX) Gross Margin % : 46.23% (As of Dec. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Tissue Regenix Group Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Tissue Regenix Group's Gross Profit for the six months ended in Dec. 2023 was £5.62 Mil. Tissue Regenix Group's Revenue for the six months ended in Dec. 2023 was £12.16 Mil. Therefore, Tissue Regenix Group's Gross Margin % for the quarter that ended in Dec. 2023 was 46.23%.

Warning Sign:

Tissue Regenix Group PLC gross margin has been in long-term decline. The average rate of decline per year is -1.2%.

The historical rank and industry rank for Tissue Regenix Group's Gross Margin % or its related term are showing as below:

LSE:TRX' s Gross Margin % Range Over the Past 10 Years
Min: 42.93 Med: 47.61 Max: 81.06
Current: 47.61

During the past 13 years, the highest Gross Margin % of Tissue Regenix Group was 81.06%. The lowest was 42.93%. And the median was 47.61%.

LSE:TRX's Gross Margin % is ranked worse than
63.9% of 748 companies
in the Biotechnology industry
Industry Median: 59.99 vs LSE:TRX: 47.61

Tissue Regenix Group had a gross margin of 46.23% for the quarter that ended in Dec. 2023 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Tissue Regenix Group was -1.20% per year.

Tissue Regenix Group Gross Margin % Historical Data

The historical data trend for Tissue Regenix Group's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tissue Regenix Group Gross Margin % Chart

Tissue Regenix Group Annual Data

Trend

Jan14

Jan15

Jan16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Gross Margin %

Get a 7-Day Free Trial

46.19

45.95

42.93

46.00

47.61

Tissue Regenix Group Semi-Annual Data
	Jan14	Jul14	Jan15	Jul15	Jan16	Jul16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Gross Margin %	Get a 7-Day Free Trial															40.37	45.80	46.18	49.11	46.23

Competitive Comparison of Tissue Regenix Group's Gross Margin %

For the Biotechnology subindustry, Tissue Regenix Group's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tissue Regenix Group's Gross Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tissue Regenix Group's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Tissue Regenix Group's Gross Margin % falls into.

Tissue Regenix Group Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Tissue Regenix Group's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )	=	Gross Profit (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	11.1	/	23.299
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(23.299 - 12.207)	/	23.299
	=	47.61 %

Tissue Regenix Group's Gross Margin for the quarter that ended in Dec. 2023 is calculated as

Gross Margin % (Q: Dec. 2023 )	=	Gross Profit (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	5.6	/	12.162
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(12.162 - 6.54)	/	12.162
	=	46.23 %

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Tissue Regenix Group (LSE:TRX) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Tissue Regenix Group had a gross margin of 46.23% for the quarter that ended in Dec. 2023 => Durable competitive advantage

Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.

Tissue Regenix Group Gross Margin % Related Terms

Thank you for viewing the detailed overview of Tissue Regenix Group's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Tissue Regenix Group (LSE:TRX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tissue Regenix Group PLC (LSE:TRX) » Definitions » Gross Margin %

Comparable Companies

Traded in Other Exchanges

LSW:Germany

Address

Lotherton Way, Unit 3, Phoenix Court, Garforth, GBR, LS25 2GY

Website

https://www.tissueregenix.com

Tissue Regenix Group PLC is a pioneering medical technology company engaged in the development of regenerative products. The company incorporates dCELL and BioRinse technology, which helps to address complex and varying clinical needs. Its product portfolio includes Biosurgery, Orthopaedics, and Dental. The company has operations around the world, with special emphasis in the United States.